Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:22 PM
Ignite Modification Date:
2025-12-24 @ 2:22 PM
NCT ID:
NCT01255995
Eligibility Criteria:
Inclusion Criteria:
* Age 40-75
* PXF with or without secondary open-angle glaucoma who present with cataract and willing to undergo phacoemulsification with IOL
* Nuclear sclerosis with LOCS III grade and above
* Pupil size more than 4mm on dilatation
* Endothelial cell count \>1,500
* No visible phacodonesis
Exclusion Criteria:
* Uncontrolled IOP/glaucoma
* History of narrow angles, chronic narrow angle glaucoma
* Any pre-existing clinical zonular dialysis or phacodonesis
* Pseudo uveitis
* One eyed patients
* Cardiac pathology
* Uncontrolled diabetes, hypertension \& severe asthma
* Obviously debilitated patients
* Traumatic cataract
* Complicated cataract
* Congenital cataract
* Drug induced cataract
* Shallow anterior Chamber
* Amblyopia
* Dense posterior polar cataract
* Corneal pathology
* Retinal pathology
* RAPD
* Severe visual field defect (MD-\>12.0dB)
* Diabetic retinopathy
* Combined Surgery
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01255995
Study Brief:
Protocol Section:
NCT01255995